IRTC
NASDAQ HealthcareiRhythm Technologies, Inc. - Common Stock
Medical Devices
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
�� 市场数据
| 价格 | $125.32 |
|---|---|
| 成交量 | 389,984 |
| 市值 | 4.05B |
| 贝塔系数 | 1.180 |
| RSI(14日) | 61.3 |
| 200日均线 | $158.06 |
| 50日均线 | $128.37 |
| 52周最高 | $212.00 |
| 52周最低 | $97.16 |
| Forward P/E | 149.84 |
| Price / Book | 26.50 |
🎯 投资策略评分
IRTC 在各投资策略中的评分。分数越高,越符合该策略目标。
🔍 策略解读
最佳匹配: 🔪 Falling Knife (88/100) — 此策略 逆向投资(超卖 + 低于移动均线).
评分最低的策略: 💰 Dividend Daddy (22/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 IRTC in your text
粘贴任何文章、记录或帖子 — 工具将提取 IRTC 以及每一个其他隐藏的股票代码。
免责声明:本数据仅供教育和娱乐用途,不构成金融建议。市场数据可能存在延迟。在做出投资决策之前,请始终进行自己的研究。
数据最后更新: 2026-04-17.